Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B‐ALL, or T‐ALL

Abstract Acute leukemia of ambiguous lineage (ALAL) is a rare, poor‐prognosis acute leukemia subtype that cannot be assigned to a single hematopoietic lineage. Although ALAL patients are typically treated with acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) regimens, optimal treat...

Full description

Bibliographic Details

Published in:	HemaSphere
Main Authors:	Roger Mulet‐Lazaro, Anikó Sijs‐Szabó, Remco M. Hoogenboezem, Stanley van Herk, Carla Exalto, Jasper E. Koenders, Patricia G. Hoogeveen, François G. Kavelaars, Anita M. Schelen, Willemijn van den Ancker, Arjan A. van deLoosdrecht, Charles G. Mullighan, H. Berna Beverloo, Vincent van der Velden, Jan J. Cornelissen, Peter J. M. Valk, Anita W. Rijneveld, Mathijs A. Sanders
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Online Access:	https://doi.org/10.1002/hem3.70195